AB Science S.A (AB) | Stock Overview & Key Data
AB Science S.A. | Small-cap | Healthcare
AB Science S.A. | Small-cap | Healthcare
AB Science S.A Performance Comparison
Stock Range
Today's Range
Low: €1.33
High: €1.39
on August 8, 2025
52 Week Range
Low: €0.77
High: €2.34
on November 25, 2024
on January 8, 2025
All-Time High: €23.00 on October 29, 2012
Explore how other French stocks compare to their 52-week ranges: View FR Market 52-Week Insights
Key Statistics
Market Cap
€84.5M
EPS
-0.15
P/E Ratio (TTM)
-8.93
Forward P/E
-6.14
P/B Ratio
N/A
PEG Ratio
-6.14
Div. Yield
N/A
ROE
32.97%
Beta
1.593
Debt to Equity
-0.78
Financial Highlights
Profitability
Gross Margin
N/A
Operating Margin
-488.48%
Profit Margin
116.42%
Returns and Earnings
Return on Assets (TTM)
-15.62%
Return on Equity (TTM)
32.97%
EBITDA
€-5.7M
Net Income (TTM)
€-7.8M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
€0.02
Quarterly Revenue Growth (YoY)
-1.90%
Quarterly Earnings Growth (YoY)
N/A
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| AB Science S.A AB | 84.48M Small-cap | -10.81% | -14.29% | -10.20% | -16.98% | 46.67% | 37.50% | -84.23% | -84.62% |
| Ipsen S.A IPN | 8.82B Large-cap | 2.70% | 3.90% | 4.00% | -12.42% | -5.84% | 2.13% | 10.44% | 21.88% |
| Vetoquinol S.A VETO | 895.57M Mid-cap | -2.59% | 0.53% | 3.16% | 2.59% | -1.05% | -20.62% | -39.17% | 2.61% |
| CoreTech Limited MLCOT | 4.03M Small-cap | -33.33% | -18.18% | 800.00% | 500.00% | 1,700.00% | 950.00% | 425.00% | 425.00% |
| Boiron S.A BOI | 368.08M Mid-cap | 0.95% | -6.40% | -15.03% | -17.67% | -20.75% | -30.61% | -55.08% | -37.74% |
| Euroapi S.A.S.U EAPI | 276.06M Mid-cap | -0.69% | -10.06% | 3.25% | -5.30% | -3.70% | -29.90% | -82.26% | -78.83% |
Ownership & Short Interest
Insider Ownership
33.19%
Institutional Ownership
0.13%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
465K
Average 90-Day Volume
377K
AB Science S.A Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in AB Science S.A would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is AB's 52-week high and low?
- In the last 52 weeks, AB Science S.A reached a high of €2.34 (on January 8, 2025) and a low of €0.77 (on November 25, 2024).
- What is the market cap and P/E ratio for AB?
- Curious about AB Science S.A's size and valuation? Its market capitalization stands at 84.48M. When it comes to valuation, the P/E ratio (trailing twelve months) is -8.93, and the forward P/E (looking ahead) is -6.14.
- Does AB pay dividends? If so, what's the yield?
- As for dividends, AB Science S.A isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are AB Science S.A's main competitors or similar companies to consider before investing?
When looking at AB Science S.A, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Ipsen S.A
IPN8.82B Healthcare Drug Manufacturers - Specialty & Generic 2.13% 10.44% Vetoquinol S.A
VETO895.57M Healthcare Drug Manufacturers - Specialty & Generic -20.62% -39.17% CoreTech Limited
MLCOT4.03M Healthcare Drug Manufacturers - Specialty & Generic 950.00% 425.00% Boiron S.A
BOI368.08M Healthcare Drug Manufacturers - Specialty & Generic -30.61% -55.08% Euroapi S.A.S.U
EAPI276.06M Healthcare Drug Manufacturers - Specialty & Generic -29.90% -82.26% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for AB Science S.A.? (e.g., ROE, Debt/Equity)
- To get a sense of AB Science S.A's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 32.97%, the Debt to Equity ratio from the most recent quarter is -0.78, and its Gross Profit Margin stands at N/A.
- What is the recent revenue and earnings growth for AB?
- Looking at AB Science S.A's growth, its revenue over the trailing twelve months (TTM) was €1M. Compared to the same quarter last year (YoY), quarterly revenue grew by -1.90%, and quarterly earnings saw a YoY growth of N/A.
- How much of AB stock is held by insiders and institutions?
- Wondering who owns AB Science S.A stock? Company insiders (like executives and directors) hold about 33.19% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 0.13%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.